首页> 外文期刊>Human Genetics >Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21
【24h】

Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21

机译:家族性青少年高尿酸血症(痛风)肾病(FJHN)的全基因组研究表明,一个新的基因座FJHN3与染色体2p22.1-p21相关

获取原文
获取原文并翻译 | 示例
       

摘要

Familial juvenile hyperuricaemic (gouty) nephropathy (FJHN), is an autosomal dominant disease associated with a reduced fractional excretion of urate, and progressive renal failure. FJHN is genetically heterogeneous and due to mutations of three genes: uromodulin (UMOD), renin (REN) and hepatocyte nuclear factor-1beta (HNF-1β) on chromosomes 16p12, 1q32.1, and 17q12, respectively. However, UMOD, REN or HNF-1β mutations are found in only ~45% of FJHN probands, indicating the involvement of other genetic loci in ~55% of probands. To identify other FJHN loci, we performed a single nucleotide polymorphism (SNP)-based genome-wide linkage analysis, in six FJHN families in whom UMOD, HNF-1β and REN mutations had been excluded. Parametric linkage analysis using a ‘rare dominant’ model established linkage in five of the six FJHN families, with a LOD score >+3, at 0% recombination, between FJHN and SNPs at chromosome 2p22.1-p21. Analysis of individual recombinants in two unrelated affected individuals defined a ~5.5 Mbp interval, flanked telomerically by SNP RS372139 and centromerically by RS896986 that contained the locus, designated FJHN3. The interval contains 28 genes, and DNA sequence analysis of the most likely candidate, solute carrier family 8 member 1 (SLC8A1), did not identify any abnormalities in the FJHN3 probands. FJHN3 is likely located within a ~5.5 Mbp interval on chromosome 2p22.1-p21, and identifying the genetic abnormality will help to further elucidate mechanisms predisposing to gout and renal failure.
机译:家族性青少年高尿酸血症(痛风)肾病(FJHN)是一种常染色体显性遗传疾病,与尿酸盐的分数排泄减少和进行性肾衰竭有关。 FJHN在遗传上是异质的,并且是由于三个基因的突变:分别在16p12、1q32.1和17q12染色体上的尿调节素(UMOD),肾素(REN)和肝细胞核因子-1β(HNF-1β)。但是,仅在约45%的FJHN先证者中发现UMOD,REN或HNF-1β突变,表明约55%的先证者参与了其他遗传基因座。为了鉴定其他FJHN基因座,我们在六个UJ,HNF-1β和REN突变被排除的FJHN家族中进行了基于单核苷酸多态性(SNP)的全基因组连锁分析。使用“罕见显性”模型进行的参数连锁分析在六个FJHN家族中的五个中建立了连锁,当重组2%时,LOJ得分> +3,位于2p22.1-p21染色体的FJHN和SNP之间。在两个不相关的受影响个体中对单个重组体的分析定义了约5.5 Mbp的间隔,端粒位于SNP RS372139的端粒侧,而位于包含命名为FJHN3的基因座的RS896986的中心端。该间隔包含28个基因,最可能的候选物,溶质载体家族8成员1(SLC8A1)的DNA序列分析未发现FJHN3先证者中的任何异常。 FJHN3可能位于2p22.1-p21染色体上约5.5 Mbp的区间内,鉴定遗传异常将有助于进一步阐明易患痛风和肾衰竭的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号